Leadless pacemakers soon available for all patients Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam UMC, an improved version will soon be available for all patients. The results of this clinical trial are, today, published in the New England Journal of Medicine.
Vegan mothers' breastmilk contains two important nutrients A vegan diet does not affect maternal breastmilk concentrations of vitamin B2 and carnitine, nutrients essential for the developing infant. These are the results of an Amsterdam UMC study, presented today at the 55th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
Combination therapy outperforms chemotherapy in patients with chronic lymphocytic leukaemia Chemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukaemia (CLL). The disease is the most common form of leukaemia in the Western world, causing a substantial health burden on patients and society. It is currently incurable. Research led by researchers from Cologne University, Amsterdam UMC and Copenhagen University, now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects. The results of this study are published today in the New England Journal of Medicine.
Cognitive behavioural therapy lessens post-viral fatigue after COVID-19 Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioural therapy, resulting in less fatigue and concentration problems. Lead researcher, Hans Knoop, Professor of Medical Psychology at Amsterdam UMC found that “After behavioural therapy, patients not only had less symptoms but also functioned better both physically and socially. Those improvements were still present even after six months.” Today, research from Amsterdam UMC, RadboudUMC and three other hospitals is published in Clinical Infectious Diseases.
Amsterdam UMC leads an AI-powered hunt for high-risk vascular patients Every year 18 million people die from cardiovascular disease. Making it the deadliest disease in the world. Currently studies focus mainly on the heart, leaving the influence of vascular disease on these large numbers of deaths often out of sight. Despite vascular disorders being a reliable indicator for death from heart disease.
Amsterdam UMC leads international consortium in the search for treatment for ME/CFS Thanks to a ZonMw grant of more than seven million euros, Amsterdam UMC kick starts new biomedical research into ME/CFS. Jos Bosch, researcher at the University of Amsterdam and Amsterdam UMC, leads along with more than 20 partners, the hunt for answers to the following questions: What exactly happens in the body of patients? How can the diagnosis be improved? And what might be effective treatments?
There's no malaria magic bullet, there may never be, but there are reasons to be optimistic Nearly half of the world's population are at risk of malaria and the hunt for a vaccine continues. But, in the view of Martin Grobusch, Professor of Tropical Medicine and Travel Medicine at Amsterdam UMC, it's not the magic bullet of a vaccine that we should be waiting for but rather getting to work on a magic gun, filled with all the options that we already have.
Long-COVID a greater burden for migrant groups than the Dutch population All prominent migrant groups in the Netherlands suffer more from long-covid than the native Dutch population, research from Amsterdam UMC has found. The study, published today, in The Lancet Regional Health – Europe, shows that in some groups the rates of long-covid are up to 50% larger than in the Dutch population. Resulting in many migrant groups “suffering in silence,” in the words of senior author Professor Charles Agyemang.
